Log In
Print
BCIQ
Print
Print this Print this
 

IDegLira (NN9068)

Also known as: Victoza-Degludec combination product

  Manage Alerts
Collapse Summary General Information
Company Novo Nordisk A/S
DescriptionFixed-dose combination of Victoza liraglutide, a long-acting analog of glucagon-like peptide-1 (GLP-1), and Tresiba insulin degludec, a long-acting insulin analog
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R)
Mechanism of Action 
Latest Stage of DevelopmentPhase III
IndicationDiabetes
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today